Online Dietary and Resistance Training to Improve Physical Function in Older Cancer Survivors, E-PROOF Trial

Sponsor
Ohio State University Comprehensive Cancer Center (Other)
Overall Status
Recruiting
CT.gov ID
NCT06016725
Collaborator
National Institute on Aging (NIA) (NIH)
70
1
2
28
2.5

Study Details

Study Description

Brief Summary

This phase I trial tests the feasibility, acceptability, and preliminary effectiveness of online dietary and resistance training to improve physical function in older (greater than or equal to 65-years old) cancer survivors. Declines in adequate protein and calorie intake results in faster loss of muscle mass and physical functioning in older adults. A novel approach to improving physical function in older cancer survivors (OCS) is to utilize online, tailored education and counseling from registered dietitians and exercise scientists, to improve dietary intake (protein intake, diet quality) and participation in resistance exercise. The purpose of this study is to help researchers learn whether an online dietary and resistance training intervention improves diet, exercise, physical function, and health outcomes in OCS.

Condition or Disease Intervention/Treatment Phase
  • Other: Exercise Intervention
  • Other: Informational Intervention
  • Other: Nutritional Assessment
  • Other: Physical Performance Testing
  • Other: Quality-of-Life Assessment
  • Other: Questionnaire Administration
N/A

Detailed Description

PRIMARY OBJECTIVES:
  1. Determine the feasibility and acceptability of implementing a 12-week online dietary and resistance training randomized trial with 70 older cancer survivors.

  2. Examine the preliminary efficacy of this 12-week online dietary and resistance training intervention with the intervention participants.

OUTLINE: Patients are randomized to 1 of 2 arms.

ARM 1: Patients participate in online nutritional counseling over 30 minutes in weeks 1, 3, 5, 7, 9, and 11, and participate in online resistance training sessions weekly over 30 minutes in weeks 1-6 and biweekly at weeks 8, 10, and 12. Patients also receive educational materials at baseline.

ARM 2: Patients receive educational materials at baseline.

After completion of study intervention, patients are followed up at 3 months.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
70 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Supportive Care
Official Title:
E-PROOF: E-Intervention for Protein Intake and Resistance Training to Optimize Function
Anticipated Study Start Date :
Sep 1, 2023
Anticipated Primary Completion Date :
Dec 31, 2024
Anticipated Study Completion Date :
Dec 31, 2025

Arms and Interventions

Arm Intervention/Treatment
Experimental: Arm 1 (nutritional counseling, resistance training)

Patients participate in online nutritional counseling over 30 minutes in weeks 1, 3, 5, 7, 9, and 11, and participate in online resistance training sessions weekly over 30 minutes in weeks 1-6 and biweekly at weeks 8, 10, and 12. Patients also receive educational materials at baseline.

Other: Exercise Intervention
Participate in online resistance training sessions

Other: Informational Intervention
Given educational materials

Other: Nutritional Assessment
Participate in online nutritional counseling
Other Names:
  • Dietary Assessment
  • dietary counseling
  • nutritional counseling
  • Other: Physical Performance Testing
    Ancillary studies
    Other Names:
  • Physical Fitness Testing
  • Physical Function Testing
  • Other: Quality-of-Life Assessment
    Ancillary studies
    Other Names:
  • Quality of Life Assessment
  • Other: Questionnaire Administration
    Ancillary studies

    Active Comparator: Arm 2 (educational materials)

    Patients receive educational materials at baseline.

    Other: Informational Intervention
    Given educational materials

    Other: Physical Performance Testing
    Ancillary studies
    Other Names:
  • Physical Fitness Testing
  • Physical Function Testing
  • Other: Quality-of-Life Assessment
    Ancillary studies
    Other Names:
  • Quality of Life Assessment
  • Other: Questionnaire Administration
    Ancillary studies

    Outcome Measures

    Primary Outcome Measures

    1. Physical function [Up to 12 weeks post study completion]

      Measured by the Short Physical Performance Battery (SPPB) score. Efficacy will be based on 12 weeks. The SPPB score is a continuous variable, collected as the total score ranging from 0-12. Group differences in SPPB scores over the time will be tested using repeated measures analysis of variance. Using the planned contrasts command, we will investigate the changes in SPPB scores within each group, and between the intervention and control groups at end-of-study. Descriptive statistics and frequency distributions will be used to characterize the sample. To examine the effect of the intervention on the changes in physical function, a linear mixed effect model will be adopted.

    Secondary Outcome Measures

    1. Satisfaction of the delivery method and information provided by nutrition and exercise counseling sessions [At 12 weeks]

      Percentage of participant satisfaction ("satisfied" and "very satisfied") measured by a 5-item Likert-scale questionnaire

    2. Study accrual rate [Up to 9 months]

      Will be calculated by dividing the number of potential participants that passed screening by the total number of participants started in the study after appropriate informed consent procedures.

    3. Study retention rate [At baseline and 12 weeks]

      Will be calculated by dividing the total number of participants initiated by total number of participants in the study. Retention goal for this trial is 80%. If 80% (56/70) of participants are retained at end-of-study, the retention goal for this trial will be achieved. Overall retention rates and associated 95% confidence intervals will be reported.

    4. Study adherence rate [At baseline, 12 weeks, and 3-month follow-up]

      Participants will be determined to be adherent if they attend >= 80% of the intervention sessions (in-person meetings with study staff and online intervention sessions). Overall adherence rates and associated 95% confidence intervals will be reported.

    5. Muscle strength [At baseline, 12 weeks, and 3-month follow-up]

      Handgrip strength will be measured in both hands using a hydraulic grip strength dynamometer. Change in participant outcome measures from baseline to end-of-study will be assessed in kilograms at the baseline and end of study visits.

    6. Dietary quality and protein intake [At baseline and 12 weeks]

      Protein intake and dietary quality will be assessed by the National Cancer Institute's Diet History Questionnaire III using the Healthy Eating Index score ranging 0-100, with higher scores meaning higher diet quality. Change in participant outcome measures from baseline to end-of-study will be assessed using the Healthy Eating Index score.

    7. Resistance exercises [At baseline and 12 weeks]

      Self-reported resistance exercise will be assessed using the revised version of The Godin-Shephard Leisure-Time Exercise Questionnaire modified to specifically capture self-reported resistance exercise participation, reported in frequency of days per week and duration in minutes. Change in participant outcome measures from baseline to end-of-study will be assessed using the reported frequency of days per week and duration in minutes.

    8. Health-related quality of life (HRQoL) physical and emotional health scores [At baseline and 12 weeks]

      RAND-36 Health Status Measure is comprised of 36 items which automatically create 8 subscales assessing multiple aspects of HRQoL. Physical and mental component summaries are created. All scores range from 0-100, with 100 as the highest. Change in participant outcome measures from baseline to end-of-study will be assessed using the RAND-36 Health Status Measure score.

    9. Self-efficacy for improving diet quality and increasing resistance training [At baseline and 12 weeks]

      Self-efficacy will be measured via a 0-10 confidence scale rating the confidence of making exercise and diet changes, with 0 meaning not confident, 10 meaning very confident. Change in participant outcome measures from baseline to end-of-study will be assessed using the confidence scale rating.

    10. Technology competency [At baseline and 12 weeks]

      The 8-item eHealth Literacy Scale will measure knowledge, comfort, and perceived skills of engaging in eHealth at baseline and end-of-study. A 5-point Likert scale will be used. Change in participant outcome measures from baseline to end-of-study will be assessed using the 5-point Likert scale score.

    11. Anthropometry body weight in kilograms [At baseline and 12 weeks]

      Change in participant outcome measure body weight from baseline to end-of-study will be assessed using body weight in kilograms.

    12. Anthropometry height in inches [At baseline and 12 weeks]

      Change in participant outcome measure height from baseline to end-of-study will be assessed using height in inches.

    13. Anthropometry measuring waist circumference in centimeters [At baseline and 12 weeks]

      Change in participant outcome measure waist circumference from baseline to end-of-study will be assessed using waist circumference in centimeters.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    65 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • = 65 years of age

    • A primary diagnosis of stage I-III breast, colorectal, and prostate cancer

    • Completion of primary curative treatment

    • Reported at least 1 physical function limitation on the RAND-36 Physical Function Subscale (PFSS) ("limited a little", "limited a lot")

    • No evidence of progressive disease or second cancers

    • Community-dwelling

    • Able to provide consent

    Exclusion Criteria:
    • Currently receive cancer treatment (e.g., chemotherapy, radiation)

    • Have liver and/or renal disease limiting their protein intake

    • Are under the care of a Registered Dietician (RD)/nutritionist

    • Participating in other diet/exercise interventions

    • Consume protein supplements

    • Have contraindications to unsupervised exercise (e.g., walker/wheelchair use)

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Ohio State University Comprehensive Cancer Center Columbus Ohio United States 43210

    Sponsors and Collaborators

    • Ohio State University Comprehensive Cancer Center
    • National Institute on Aging (NIA)

    Investigators

    • Principal Investigator: Jessica L Krok-Schoen, PhD, Ohio State University Comprehensive Cancer Center

    Study Documents (Full-Text)

    None provided.

    More Information

    Additional Information:

    Publications

    None provided.
    Responsible Party:
    Jessica Krok-Schoen, Principal Investigator, Ohio State University Comprehensive Cancer Center
    ClinicalTrials.gov Identifier:
    NCT06016725
    Other Study ID Numbers:
    • OSU-22329
    • NCI-2023-04622
    • R21AG078258
    First Posted:
    Aug 30, 2023
    Last Update Posted:
    Sep 1, 2023
    Last Verified:
    Aug 1, 2023
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Sep 1, 2023